Telesis Bio secures up to $21M to accelerate adoption of Gibson SOLA



Telesis Bio secures up to $21M to accelerate adoption of Gibson SOLA

  • Telesis Bio (OTC: Tbio) has entered into a convertible preferred stock purchase agreement to sell shares of a new series of convertible preferred stock in a private placement for gross proceeds of up to around $21M.
  • The purchase agreement provides for



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *